ST華西(002630.SZ):簽訂3.47億美元合同
格隆匯5月28日丨ST華西(002630.SZ)公佈,公司、蚌埠市國際經濟技術合作有限公司(簡稱“供方2”)組成的聯合體與阿聯酋Al-NukhbaOFSFZ-LLC公司(簡稱“需方”)簽訂了《伊拉克巴格達Al-Daura熱電廠修復工程、設計、採購及施工安裝分包合同》(簡稱“合同”),合同總價爲3.47億美元。其中公司作爲項目實施方,負責合同項目設計、設備供貨、施工改造、安裝調試等工作,對應合同金額2.9億美元(摺合人民幣約20.84億元)、約佔公司最近一期經審計營業收入的80.38%。供方2作爲聯合體牽頭方,負責合同涉及與業主方、需方及其他第三方的所有對外商務工作及項目的溝通協調聯絡等工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.